G protein-coupled receptors and the modification of FcεRI-mediated mast cell activation

Immunology Letters

Volumn 113, Issue 2, 2007, Pages 59-69

  Kuehn, Hye Sun ^a   Gilfillan, Alasdair M ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Antigen; Fc RI; G protein coupled receptors; IgE; Mast cells; Signalling

Indexed keywords

ADENOSINE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CHEMOKINE; COMPLEMENT COMPONENT C3A; G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; IMMUNOGLOBULIN E RECEPTOR; LYSOPHOSPHATIDIC ACID; PROSTAGLANDIN E2; PURINERGIC RECEPTOR STIMULATING AGENT; SPHINGOSINE 1 PHOSPHATE;

CELL ACTIVATION; CELL FUNCTION; HUMAN; MAST CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN MODIFICATION; REVIEW;

ANIMALS; CELL DEGRANULATION; CHEMOKINES; HUMANS; IMMUNOGLOBULIN E; LIGANDS; MAST CELLS; RECEPTOR AGGREGATION; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, IGE; SIGNAL TRANSDUCTION;

EID: 35248863859     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2007.08.007     Document Type: Review

References (129)

1. Galli S.J., Nakae S., and Tsai M. Mast cells in the development of adaptive immune responses. Nat Immunol 6 (2005) 135-142
2. Marshall J.S. Mast-cell responses to pathogens. Nat Rev Immunol 4 (2004) 787-799
3. Tkaczyk C., Jensen B.M., Iwaki S., and Gilfillan A.M. Adaptive and innate immune reactions regulating mast cell activation: from receptor-mediated signaling to responses. Immunol Allergy Clin North Am 26 (2006) 427-450
4. Metcalfe D.D., Baram D., and Mekori Y.A. Mast cells. Physiol Rev 77 (1997) 1033-1079
5. Metzger H. The receptor with high affinity for IgE. Immunol Rev 125 (1992) 37-48
6. Gilfillan A.M., and Tkaczyk C. Integrated signalling pathways for mast-cell activation. Nat Rev Immunol 6 (2006) 218-230
7. Fujishima H., Sanchez Mejia R.O., Bingham III C.O., Lam B.K., Sapirstein A., Bonventre J.V., et al. Cytosolic phospholipase A2 is essential for both the immediate and the delayed phases of eicosanoid generation in mouse bone marrow-derived mast cells. Proc Natl Acad Sci USA 96 (1999) 4803-4807
8. Tkaczyk C., Horejsi V., Iwaki S., Draber P., Samelson L.E., Satterthwaite A.B., et al. NTAL phosphorylation is a pivotal link between the signaling cascades leading to human mast cell degranulation following Kit activation and FcεRI aggregation. Blood 104 (2004) 207-214
9. Hundley T.R., Gilfillan A.M., Tkaczyk C., Andrade M.V., Metcalfe D.D., and Beaven M.A. Kit and FcεRI mediate unique and convergent signals for release of inflammatory mediators from human mast cells. Blood 104 (2004) 2410-2417
10. Bischoff S.C., and Dahinden C.A. c-kit ligand: a unique potentiator of mediator release by human lung mast cells. J Exp Med 175 (1992) 237-244
11. Iwaki S., Tkaczyk C., Satterthwaite A.B., Halcomb K., Beaven M.A., Metcalfe D.D., et al. Btk plays a crucial role in the amplification of FcεRI-mediated mast cell activation by kit. J Biol Chem 280 (2005) 40261-40270
12. Galli S.J., Tsai M., and Wershil B.K. The c-kit receptor, stem cell factor, and mast cells. What each is teaching us about the others. Am J Pathol 142 (1993) 965-974
13. Okayama Y., and Kawakami T. Development, migration, and survival of mast cells. Immunol Res 34 (2006) 97-115
14. Qiao H., Andrade M.V., Lisboa F.A., Morgan K., and Beaven M.A. FcεR1 and toll-like receptors mediate synergistic signals to markedly augment production of inflammatory cytokines in murine mast cells. Blood 107 (2006) 610-618
15. Taub D., Dastych J., Inamura N., Upton J., Kelvin D., Metcalfe D., et al. Bone marrow-derived murine mast cells migrate, but do not degranulate, in response to chemokines. J Immunol 154 (1995) 2393-2402
16. Olivera A., and Rivera J. Sphingolipids and the balancing of immune cell function: lessons from the mast cell. J Immunol 174 (2005) 1153-1158
17. Hughes P.J., Holgate S.T., and Church M.K. Adenosine inhibits and potentiates IgE-dependent histamine release from human lung mast cells by an A2-purinoceptor mediated mechanism. Biochem Pharmacol 33 (1984) 3847-3852
18. Wang X.S., Lau H.Y., and Prostaglandin. E potentiates the immunologically stimulated histamine release from human peripheral blood-derived mast cells through EP1/EP3 receptors. Allergy 61 (2006) 503-506
19. Kay L.J., Yeo W.W., and Peachell P.T. Prostaglandin E2 activates EP2 receptors to inhibit human lung mast cell degranulation. Br J Pharmacol 147 (2006) 707-713
20. Feng C., Beller E.M., Bagga S., and Boyce J.A. Human mast cells express multiple EP receptors for prostaglandin E2 that differentially modulate activation responses. Blood 107 (2006) 3243-3250
21. Bockaert J., and Pin J.P. Molecular tinkering of G protein-coupled receptors: an evolutionary success. EMBO J 18 (1999) 1723-1729
22. Wess J. G-protein-coupled receptors: molecular mechanisms involved in receptor activation and selectivity of G-protein recognition. FASEB J 11 (1997) 346-354
23. Hamm H.E., and Gilchrist A. Heterotrimeric G proteins. Curr Opin Cell Biol 8 (1996) 189-196
24. Gilman A.G. G proteins: transducers of receptor-generated signals. Annu Rev Biochem 56 (1987) 615-649
25. Simon M.I., Strathmann M.P., and Gautam N. Diversity of G proteins in signal transduction. Science 252 (1991) 802-808
26. Bence K., Ma W., Kozasa T., and Huang X.Y. Direct stimulation of Bruton's tyrosine kinase by G(q)-protein α-subunit. Nature 389 (1997) 296-299
27. Kehrl J.H., and Heterotrimeric. G protein signaling: roles in immune function and fine-tuning by RGS proteins. Immunity 8 (1998) 1-10
28. Albert P.R., and Robillard L. G protein specificity: traffic direction required. Cell Signal 14 (2002) 407-418
29. Clapham D.E., and Neer E.J. G protein βγ subunits. Annu Rev Pharmacol Toxicol 37 (1997) 167-203
30. Papadopoulos E.J., Fitzhugh D.J., Tkaczyk C., Gilfillan A.M., Sassetti C., Metcalfe D.D., et al. Mast cells migrate, but do not degranulate, in response to fractalkine, a membrane-bound chemokine expressed constitutively in diverse cells of the skin. Eur J Immunol 30 (2000) 2355-2361
31. Romagnani P., De Paulis A., Beltrame C., Annunziato F., Dente V., Maggi E., et al. Tryptase-chymase double-positive human mast cells express the eotaxin receptor CCR3 and are attracted by CCR3-binding chemokines. Am J Pathol 155 (1999) 1195-1204
32. Kushnir-Sukhov N.M., Gilfillan A.M., Coleman J.W., Brown J.M., Bruening S., Toth M., et al. 5-Hydroxytryptamine induces mast cell adhesion and migration. J Immunol 177 (2006) 6422-6432
33. Ali H., and Panettieri Jr. R.A. Anaphylatoxin C3a receptors in asthma. Respir Res 6 (2005) 19
34. Hartmann K., Henz B.M., Kruger-Krasagakes S., Kohl J., Burger R., Guhl S., et al. C3a and C5a stimulate chemotaxis of human mast cells. Blood 89 (1997) 2863-2870
35. Thangam E.B., Venkatesha R.T., Zaidi A.K., Jordan-Sciutto K.L., Goncharov D.A., Krymskaya V.P., et al. Airway smooth muscle cells enhance C3a-induced mast cell degranulation following cell-cell contact. FASEB J 19 (2005) 798-800
36. Venkatesha R.T., Berla Thangam E., Zaidi A.K., and Ali H. Distinct regulation of C3a-induced MCP-1/CCL2 and RANTES/CCL5 production in human mast cells by extracellular signal regulated kinase and PI3 kinase. Mol Immunol 42 (2005) 581-587
37. Erdei A., Andreev S., and Pecht I. Complement peptide C3a inhibits IgE-mediated triggering of rat mucosal mast cells. Int Immunol 7 (1995) 1433-1439
38. Andrasfalvy M., Peterfy H., Toth G., Matko J., Abramson J., Kerekes K., et al. The beta subunit of the type I Fcε receptor is a target for peptides inhibiting IgE-mediated secretory response of mast cells. J Immunol 175 (2005) 2801-2806
39. Woolhiser M.R., Brockow K., and Metcalfe D.D. Activation of human mast cells by aggregated IgG through FcγRI: additive effects of C3a. Clin Immunol 110 (2004) 172-180
40. Mousli M., Hugli T.E., Landry Y., and Bronner C. A mechanism of action for anaphylatoxin C3a stimulation of mast cells. J Immunol 148 (1992) 2456-2461
41. Nilsson G., Johnell M., Hammer C.H., Tiffany H.L., Nilsson K., Metcalfe D.D., et al. C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway. J Immunol 157 (1996) 1693-1698
42. Goetzl E.J., Wang W., McGiffert C., Huang M.C., and Graler M.H. Sphingosine 1-phosphate and its G protein-coupled receptors constitute a multifunctional immunoregulatory system. J Cell Biochem 92 (2004) 1104-1114
43. Rosen H., and Goetzl E.J. Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network. Nat Rev Immunol 5 (2005) 560-570
44. Olivera A., Urtz N., Mizugishi K., Yamashita Y., Gilfillan A.M., Furumoto Y., et al. IgE-dependent activation of sphingosine kinases 1 and 2 and secretion of sphingosine 1-phosphate requires Fyn kinase and contributes to mast cell responses. J Biol Chem 281 (2006) 2515-2525
45. Jolly P.S., Bektas M., Olivera A., Gonzalez-Espinosa C., Proia R.L., Rivera J., et al. Transactivation of sphingosine-1-phosphate receptors by FcεRI triggering is required for normal mast cell degranulation and chemotaxis. J Exp Med 199 (2004) 959-970
46. Siehler S., and Manning D.R. Pathways of transduction engaged by sphingosine 1-phosphate through G protein-coupled receptors. Biochim Biophys Acta 1582 (2002) 94-99
47. Lee H.S., Park C.S., Lee Y.M., Suk H.Y., Clemons T.C., and Choi O.H. Antigen-induced Ca2+mobilization in RBL-2H3 cells: role of I(1,4,5)P3 and S1P and necessity of I(1,4 5)P3 production. Cell Calc 38 (2005) 581-592
48. Choi O.H., Kim J.H., and Kinet J.P. Calcium mobilization via sphingosine kinase in signalling by the FcεRI antigen receptor. Nature 380 (1996) 634-636
49. Jolly P.S., Bektas M., Watterson K.R., Sankala H., Payne S.G., Milstien S., et al. Expression of SphK1 impairs degranulation and motility of RBL-2H3 mast cells by desensitizing S1P receptors. Blood 105 (2005) 4736-4742
50. Matsuyuki H., Maeda Y., Yano K., Sugahara K., Chiba K., Kohno T., et al. Involvement of sphingosine 1-phosphate (S1P) receptor type 1 and type 4 in migratory response of mouse T cells toward S1P. Cell Mol Immunol 3 (2006) 429-437
51. Mitra P., Oskeritzian C.A., Payne S.G., Beaven M.A., Milstien S., and Spiegel S. Role of ABCC1 in export of sphingosine-1-phosphate from mast cells. Proc Natl Acad Sci USA 103 (2006) 16394-16399
52. Olivera A., Mizugishi K., Tikhonova A., Ciaccia L., Odom S., Proia R.L., et al. The sphingosine kinase-sphingosine-1-phosphate axis is a determinant of mast cell function and anaphylaxis. Immunity 26 (2007) 287-297
53. Bagga S., Price K.S., Lin D.A., Friend D.S., Austen K.F., and Boyce J.A. Lysophosphatidic acid accelerates the development of human mast cells. Blood 104 (2004) 4080-4087
54. Lin D.A., and Boyce J.A. IL-4 regulates MEK expression required for lysophosphatidic acid-mediated chemokine generation by human mast cells. J Immunol 175 (2005) 5430-5438
55. Hashimoto T., Ohata H., and Honda K. Lysophosphatidic acid (LPA) induces plasma exudation and histamine release in mice via LPA receptors. J Pharmacol Sci 100 (2006) 82-87
56. Hashimoto T., Ohata H., Momose K., and Honda K. Lysophosphatidic acid induces histamine release from mast cells and skin fragments. Pharmacology 75 (2005) 13-20
57. Marshall J.S., Gomi K., Blennerhassett M.G., and Bienenstock J. Nerve growth factor modifies the expression of inflammatory cytokines by mast cells via a prostanoid-dependent mechanism. J Immunol 162 (1999) 4271-4276
58. Harris S.G., Padilla J., Koumas L., Ray D., and Phipps R.P. Prostaglandins as modulators of immunity. Trends Immunol 23 (2002) 144-150
59. Vancheri C., Mastruzzo C., Sortino M.A., and Crimi N. The lung as a privileged site for the beneficial actions of PGE2. Trends Immunol 25 (2004) 40-46
60. Sugimoto Y., Narumiya S., and Prostaglandin. E receptors. J Biol Chem 282 (2007) 11613-11617
61. Gomi K., Zhu F.G., and Marshall J.S. Prostaglandin E2 selectively enhances the IgE-mediated production of IL-6 and granulocyte-macrophage colony-stimulating factor by mast cells through an EP1/EP3-dependent mechanism. J Immunol 165 (2000) 6545-6552
62. Nguyen M., Solle M., Audoly L.P., Tilley S.L., Stock J.L., McNeish J.D., et al. Receptors and signaling mechanisms required for prostaglandin E2-mediated regulation of mast cell degranulation and IL-6 production. J Immunol 169 (2002) 4586-4593
63. Polosa R., and Holgate S.T. Adenosine receptors as promising therapeutic targets for drug development in chronic airway inflammation. Curr Drug Targets 7 (2006) 699-706
64. Driver A.G., Kukoly C.A., Ali S., and Mustafa S.J. Adenosine in bronchoalveolar lavage fluid in asthma. Am Rev Respir Dis 148 (1993) 91-97
65. Forsythe P., and Ennis M. Adenosine, mast cells and asthma. Inflamm Res 48 (1999) 301-307
66. Laffargue M., Calvez R., Finan P., Trifilieff A., Barbier M., Altruda F., et al. Phosphoinositide 3-kinase γ is an essential amplifier of mast cell function. Immunity 16 (2002) 441-451
67. Gilfillan A.M., Wiggan G.A., and Welton A.F. Pertussis toxin pretreatment reveals differential effects of adenosine analogs on IgE-dependent histamine and peptidoleukotriene release from RBL-2H3 cells. Biochim Biophys Acta 1052 (1990) 467-474
68. Ramkumar V., Stiles G.L., Beaven M.A., and Ali H. The A3 adenosine receptor is the unique adenosine receptor which facilitates release of allergic mediators in mast cells. J Biol Chem 268 (1993) 16887-16890
69. Ryzhov S., Goldstein A.E., Biaggioni I., and Feoktistov I. Cross-talk between G(s)- and G(q)-coupled pathways in regulation of interleukin-4 by A(2B) adenosine receptors in human mast cells. Mol Pharmacol 70 (2006) 727-735
70. Feoktistov I., and Biaggioni I. Adenosine A2b receptors evoke interleukin-8 secretion in human mast cells An enprofylline-sensitive mechanism with implications for asthma. J Clin Invest 96 (1995) 1979-1986
71. Duffy S.M., Cruse G., Brightling C.E., and Bradding P. Adenosine closes the K+channel KCa3 1 in human lung mast cells and inhibits their migration via the adenosine A2A receptor. Eur J Immunol 37 (2007) 1653-1662
72. Zhong H., Shlykov S.G., Molina J.G., Sanborn B.M., Jacobson M.A., Tilley S.L., et al. Activation of murine lung mast cells by the adenosine A3 receptor. J Immunol 171 (2003) 338-345
73. Suzuki H., Takei M., Nakahata T., and Fukamachi H. Inhibitory effect of adenosine on degranulation of human cultured mast cells upon cross-linking of FcεRI. Biochem Biophys Res Commun 242 (1998) 697-702
74. Linden J., Thai T., Figler H., Jin X., and Robeva A.S. Characterization of human A(2B) adenosine receptors: radioligand binding, Western blotting, and coupling to G(q) in human embryonic kidney 293 cells and HMC-1 mast cells. Mol Pharmacol 56 (1999) 705-713
75. Salvatore C.A., Tilley S.L., Latour A.M., Fletcher D.S., Koller B.H., and Jacobson M.A. Disruption of the A(3) adenosine receptor gene in mice and its effect on stimulated inflammatory cells. J Biol Chem 275 (2000) 4429-4434
76. Yamano K., Inoue M., Masaki S., Saki M., Ichimura M., and Satoh M. Human adenosine A(3) receptor leads to intracellular Ca(2+) mobilization but is insufficient to activate the signaling pathway via phosphoinositide 3-kinase gamma in mice. Biochem Pharmacol 70 (2005) 1487-1496
77. Abbracchio M.P., and Burnstock G. Purinoceptors: are there families of P2X and P2Y purinoceptors?. Pharmacol Ther 64 (1994) 445-475
78. Dubyak G.R., and el-Moatassim C. Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides. Am J Physiol 265 (1993) C577-C606
79. Feng C., Mery A.G., Beller E.M., Favot C., and Boyce J.A. Adenine nucleotides inhibit cytokine generation by human mast cells through a Gs-coupled receptor. J Immunol 173 (2004) 7539-7547
80. Jaffar Z.H., and Pearce F.L. Histamine secretion from mast cells stimulated with ATP. Agents Actions 30 (1990) 64-66
81. Saito H., Sakaguchi N., Ebisawa M., Matsumoto K., Akasawa A., and Iikura Y. The stimuli releasing histamine from murine bone marrow-derived mast cells. 2. Mechanisms involved in histamine release induced by extracellular ATP and its metabolites. Arerugi 40 (1991) 680-688
82. Osipchuk Y., and Cahalan M. Cell-to-cell spread of calcium signals mediated by ATP receptors in mast cells. Nature 359 (1992) 241-244
83. Schulman E.S., Glaum M.C., Post T., Wang Y., Raible D.G., Mohanty J., et al. ATP modulates anti-IgE-induced release of histamine from human lung mast cells. Am J Respir Cell Mol Biol 20 (1999) 530-537
84. Nakajima T., Inagaki N., Tanaka H., Tanaka A., Yoshikawa M., Tamari M., et al. Marked increase in CC chemokine gene expression in both human and mouse mast cell transcriptomes following Fcε receptor I cross-linking: an interspecies comparison. Blood 100 (2002) 3861-3868
85. Kambayashi T., and Koretzky G.A. Proximal signaling events in FcεRI-mediated mast cell activation. J Allergy Clin Immunol 119 (2007) 544-552 [quiz 53-54]
86. Zlotnik A., and Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 12 (2000) 121-127
87. Murray L.A., Syed F., Li L., Griswold D.E., and Das A.M. Role of chemokines in severe asthma. Curr Drug Targets 7 (2006) 579-588
88. Romagnani S. Cytokines and chemoattractants in allergic inflammation. Mol Immunol 38 (2002) 881-885
89. Pease J.E. Asthma, allergy and chemokines. Curr Drug Targets 7 (2006) 3-12
90. Zhao Z.Z., Sugerman P.B., Zhou X.J., Walsh L.J., and Savage N.W. Mast cell degranulation and the role of T cell RANTES in oral lichen planus. Oral Dis 7 (2001) 246-251
91. Castellani M.L., Petrarca C., Frydas S., Conti C.M., Salini V., Conti P., et al. Rat basophilic leukemia cells (RBL-2H3) generate prostaglandin D2 (PGD2) after regulated upon activation, normal T-cell expressed and secreted (RANTES) activation. Int J Biol Markers 21 (2006) 211-217
92. Juremalm M., Olsson N., and Nilsson G. Selective CCL5/RANTES-induced mast cell migration through interactions with chemokine receptors CCR1 and CCR4. Biochem Biophys Res Commun 297 (2002) 480-485
93. Toda M., Dawson M., Nakamura T., Munro P.M., Richardson R.M., Bailly M., et al. Impact of engagement of FcεRI and CC chemokine receptor 1 on mast cell activation and motility. J Biol Chem 279 (2004) 48443-48448
94. Miyazaki D., Nakamura T., Toda M., Cheung-Chau K.W., Richardson R.M., and Ono S.J. Macrophage inflammatory protein-1α as a costimulatory signal for mast cell-mediated immediate hypersensitivity reactions. J Clin Invest 115 (2005) 434-442
95. Waldeck B. β-adrenoceptor agonists and asthma-100 years of development. Eur J Pharmacol 445 (2002) 1-12
96. Peachell P. Regulation of mast cells by β-agonists. Clin Rev Allergy Immunol 31 (2006) 131-142
97. Wang X.S., and Lau H.Y. β-adrenoceptor-mediated inhibition of mediator release from human peripheral blood-derived mast cells. Clin Exp Pharmacol Physiol 33 (2006) 746-750
98. Akabane H., Murata M., Kubota M., Takashima E., Tanaka H., Inagaki N., et al. Effects of salmeterol xinafoate and fluticasone propionate on immunological activation of human cultured mast cells. Allergol Int 55 (2006) 387-393
99. 2-agonists: inhibition of TNF-α release from human mast cells. J Allergy Clin Immunol 100 (1997) 825-831
100. Weston M.C., and Peachell P.T. Regulation of human mast cell and basophil function by camp. Gen Pharmacol 31 (1998) 715-719
101. Rivera J., and Gilfillan A.M. Molecular regulation of mast cell activation. J Allergy Clin Immunol 117 (2006) 1214-1225 [quiz 26]
102. Kraft S., and Kinet J.P. New developments in FcεRI regulation, function and inhibition. Nat Rev Immunol 7 (2007) 365-378
103. Kovarova M., Tolar P., Arudchandran R., Draberova L., Rivera J., and Draber P. Structure-function analysis of Lyn kinase association with lipid rafts and initiation of early signaling events after Fcε receptor I aggregation. Mol Cell Biol 21 (2001) 8318-8328
104. Field K.A., Holowka D., and Baird B. Structural aspects of the association of FcεRI with detergent-resistant membranes. J Biol Chem 274 (1999) 1753-1758
105. Yamashita T., Mao S.Y., and Metzger H. Aggregation of the high-affinity IgE receptor and enhanced activity of p53/56lyn protein-tyrosine kinase. Proc Natl Acad Sci USA 91 (1994) 11251-11255
106. Vonakis B.M., Chen H., Haleem-Smith H., and Metzger H. The unique domain as the site on Lyn kinase for its constitutive association with the high affinity receptor for IgE. J Biol Chem 272 (1997) 24072-24080
107. Eiseman E., and Bolen J.B. Engagement of the high-affinity IgE receptor activates src protein-related tyrosine kinases. Nature 355 (1992) 78-80
108. Chen T., Repetto B., Chizzonite R., Pullar C., Burghardt C., Dharm E., et al. Interaction of phosphorylated FcεRIγ immunoglobulin receptor tyrosine activation motif-based peptides with dual and single SH2 domains of p72syk. Assessment of binding parameters and real time binding kinetics. J Biol Chem 271 (1996) 25308-25315
109. Saitoh S., Arudchandran R., Manetz T.S., Zhang W., Sommers C.L., Love P.E., et al. LAT is essential for FcεRI-mediated mast cell activation. Immunity 12 (2000) 525-535
110. Iwaki S, Jensen BM, Gilfillan AM. Ntal/Lab/Lat2. Int J Biochem Cell Biol 2007;39:868-73.
111. Rivera J. NTAL/LAB and LAT: a balancing act in mast-cell activation and function. Trends Immunol 26 (2005) 119-122
112. Silverman M.A., Shoag J., Wu J., and Koretzky G.A. Disruption of SLP-76 interaction with Gads inhibits dynamic clustering of SLP-76 and FcεRI signaling in mast cells. Mol Cell Biol 26 (2006) 1826-1838
113. Rhee S.G. Regulation of phosphoinositide-specific phospholipase C. Annu Rev Biochem 70 (2001) 281-312
114. Beaven M.A., and Metzger H. Signal transduction by Fc receptors: the FcεRI case. Immunol Today 14 (1993) 222-226
115. Bell R.M., and Burns D.J. Lipid activation of protein kinase C. J Biol Chem 266 (1991) 4661-4664
116. Ozawa K., Szallasi Z., Kazanietz M.G., Blumberg P.M., Mischak H., Mushinski J.F., et al. Ca(2+)-dependent and Ca(2+)-independent isozymes of protein kinase C mediate exocytosis in antigen-stimulated rat basophilic RBL-2H3 cells. Reconstitution of secretory responses with Ca2+and purified isozymes in washed permeabilized cells. J Biol Chem 268 (1993) 1749-1756
117. 1-dependent pathway of FcεRI-mediated mast cell activation is regulated independently of phosphatidylinositol 3-kinase. J Biol Chem 278 (2003) 48474-48484
118. Parravicini V., Gadina M., Kovarova M., Odom S., Gonzalez-Espinosa C., Furumoto Y., et al. Fyn kinase initiates complementary signals required for IgE-dependent mast cell degranulation. Nat Immunol 3 (2002) 741-748
119. Ali K., Bilancio A., Thomas M., Pearce W., Gilfillan A.M., Tkaczyk C., et al. Essential role for the p110δ phosphoinositide 3-kinase in the allergic response. Nature 431 (2004) 1007-1011
120. Cantrell D.A. Phosphoinositide 3-kinase signalling pathways. J Cell Sci 114 (2001) 1439-1445
121. Cantley L.C. The phosphoinositide 3-kinase pathway. Science 296 (2002) 1655-1657
122. Lu-Kuo J.M., Fruman D.A., Joyal D.M., Cantley L.C., and Katz H.R. Impaired kit- but not FcεRI-initiated mast cell activation in the absence of phosphoinositide 3-kinase p85α gene products. J Biol Chem 275 (2000) 6022-6029
123. Gomez G., Gonzalez-Espinosa C., Odom S., Baez G., Cid M.E., Ryan J.J., et al. Impaired FcεRI-dependent gene expression and defective eicosanoid and cytokine production as a consequence of Fyn deficiency in mast cells. J Immunol 175 (2005) 7602-7610
124. Bingham CO, 3rd, Austen KF. Phospholipase A2 enzymes in eicosanoid generation. Proc Assoc Am Phys 1999;111:516-24.
125. Lorentz A., Klopp I., Gebhardt T., Manns M.P., and Bischoff S.C. Role of activator protein 1, nuclear factor-κB, and nuclear factor of activated T cells in IgE receptor-mediated cytokine expression in mature human mast cells. J Allergy Clin Immunol 111 (2003) 1062-1068
126. Kitaura J., Asai K., Maeda-Yamamoto M., Kawakami Y., Kikkawa U., and Kawakami T. Akt-dependent cytokine production in mast cells. J Exp Med 192 (2000) 729-740
127. Fruman D.A., and Cantley L.C. Phosphoinositide 3-kinase in immunological systems. Semin Immunol 14 (2002) 7-18
128. Nakamura H., Saito H., and Ikura Y. The stimuli releasing histamine from murine bone marrow-derived mast cells. 1. The presence of P2-purinoceptors. Arerugi 38 (1989) 1359-1363
129. Budagian V., Bulanova E., Brovko L., Orinska Z., Fayad R., Paus R., et al. Signaling through P2X7 receptor in human T cells involves p56lck, MAP kinases, and transcription factors AP-1 and NF-κB. J Biol Chem 278 (2003) 1549-1560